Increased myocardial contractility identifies patients with decompensated cirrhosis requiring liver transplantation

Christian Jansen1, Alexander Cox1, Robert Schueler2

  • 1Departments of Internal Medicine I.

Insights

Increased myocardial contractility in patients awaiting liver transplantation (LT) signals an earlier need for the procedure. This finding, using speckle tracking echocardiography, did not correlate with worse outcomes after LT, highlighting its prognostic value for transplant allocation.

Area of Science:

  • Cardiology
  • Hepatology
  • Transplantation Medicine

Background:

  • Cardiac dysfunction is common in cirrhosis and impacts liver transplantation (LT) prognosis.
  • The role of myocardial contractility in LT allocation is not well understood.
  • Existing research controversially discusses the prognostic value of myocardial contractility.

Purpose of the Study:

  • To investigate the role of myocardial contractility, assessed by speckle tracking echocardiography, in liver transplantation (LT) allocation.
  • To determine the prognostic value of myocardial contractility in patients with cirrhosis awaiting LT.
  • To analyze the association between myocardial contractility and transplant-free survival.

Main Methods:

  • Retrospective analysis of 168 patients with cirrhosis awaiting LT across two centers.
  • Utilized speckle tracking echocardiography to assess left ventricular (LV) myocardial contractility.
  • Employed competing risk analysis to evaluate the association with LT timing and survival.

Main Results:

  • Left ventricular (LV) contractility increased with Child-Pugh score severity.
  • Higher LV contractility independently predicted reduced transplant-free survival, particularly in Child-Pugh C patients.
  • Increased myocardial contractility was associated with earlier LT, confirmed in a validation cohort, and did not impact post-LT survival.

Conclusions:

  • Increased myocardial contractility in decompensated cirrhotic patients identifies those needing earlier LT.
  • Myocardial contractility assessment can aid in optimizing LT allocation decisions.
  • This finding suggests that increased contractility is a marker for LT urgency, not post-transplant risk.

Related Concept Videos

Cardiomyopathy II: Dilated Cardiomyopathy01:30

Cardiomyopathy II: Dilated Cardiomyopathy

Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...
648
Cardiomyopathy V: Interprofessional Care01:29

Cardiomyopathy V: Interprofessional Care

Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...
510
Imbalances in Cardiac Output01:26

Imbalances in Cardiac Output

The heart's primary function is to pump blood throughout the body, maintaining a balance between blood sent out (cardiac output) and blood returning (venous return). If this balance is disrupted, it can result in congestive heart failure (CHF), a severe condition where the heart becomes an inefficient pump, leading to inadequate blood circulation.
CHF can occur due to the failure of either side of the heart. Left-side failure leads to pulmonary congestion—the right side continues to send...
3.3K
Cardiomyopathy III: Hypertrophic Cardiomyopathy01:29

Cardiomyopathy III: Hypertrophic Cardiomyopathy

Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
553
Effect of Hepatic Disease on Pharmacokinetics: Pathophysiologic Assessment and Liver Function Test01:22

Effect of Hepatic Disease on Pharmacokinetics: Pathophysiologic Assessment and Liver Function Test

In clinical practice, the direct measurement of hepatic blood flow to evaluate liver function presents significant challenges due to the intricate and specialized nature of the necessary techniques. Consequently, healthcare professionals often rely on empirical estimates derived from thorough patient examinations and liver function tests to gauge liver health. Among the tools at their disposal, the Child–Pugh and MELD scoring systems stand out for their ability to categorize and assess...
225
Cardiomyopathy IV: Restrictive Cardiomyopathy01:29

Cardiomyopathy IV: Restrictive Cardiomyopathy

Restrictive cardiomyopathy (RCM) is a rare heart muscle disease characterized by impaired ventricular filling due to stiffened ventricular walls, leading to significant diastolic dysfunction.EtiologyRestrictive cardiomyopathy can arise from both inherited and acquired diseases, many of which are systemic. It is categorized into four main types: infiltrative, storage, non-infiltrative, and endomyocardial diseases.Infiltrative diseases, such as amyloidosis, lead to RCM by depositing amyloid...
632